🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a study to evaluate the clinical activity of the combination of flu...
Status
Active Not Recruiting
Location
Lombardi Comprehensive Cancer Center, Georgetown University
Start Date
2019-07-29
Trial ID
NCT04005339
Treatments Being Tested
The overarching hypothesis of this trial is that the NAPOLI regimen and alt...
Status
Unknown
Location
Klinikum der Universitaet Muenchen - Campus Grosshadern
Start Date
2019-02-15
Trial ID
NCT03487016
Treatments Being Tested
This is an investigator-initiated, prospective, multicenter, single-arm pha...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2024-09-01
Trial ID
NCT07047560
This is a phase II, single arm, non-randomized, open label study of liposom...
Status
Active Not Recruiting
Location
University of Florida
Start Date
2018-12-13
Trial ID
NCT03483038
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of combina...
Status
Completed
Location
Asan Medical Center
Start Date
2018-09-04
Trial ID
NCT03524508
This is a prospective, single-center, single-arm study evaluating the combi...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute & Hospital
Start Date
2025-11-01
Trial ID
NCT07281157
Treatments Being Tested
This trial is a multi-center, open-label, phase I, dose escalation study of...
Status
Completed
Location
Multiple Locations
Start Date
2006-01
Trial ID
NCT02884128
This is a Phase Ib/II platform clinical study to evaluate the initial effic...
Status
Not Yet Recruiting
Location
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Start Date
2024-04-30
Trial ID
NCT06370754
This is a prospective, Bayesian adaptive, phase II clinical trial designed ...
Status
Recruiting
Location
Cancer Center of Guangzhou Medical University
Start Date
2025-06-24
Trial ID
NCT07070479
Using alternative neoadjuvant gemcitabine-nab-paclitaxel and nal-IRI with 5...
Status
Unknown
Location
Virginia mason medical Center
Start Date
2018-09-17
Trial ID
NCT03703063
Treatments Being Tested